---
title: The Inhibition of MSH6 Augments the Antineoplastic Efficacy of Cisplatin in
  Non-Small Cell Lung Cancer as Autophagy Modulator
date: '2024-08-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39168426/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240822181408&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: The altered response to chemotherapeutic agents predominantly stems from
  heightened single-point mutations within coding regions and dysregulated expression
  levels of genes implicated in drug resistance mechanisms. The identification of
  biomarkers based on mutation profiles and expression levels is pivotal for elucidating
  the underlying mechanisms of altered drug responses and for refining combinatorial
  therapeutic strategies in the field of oncology. Utilizing comprehensive ...
disable_comments: true
---
The altered response to chemotherapeutic agents predominantly stems from heightened single-point mutations within coding regions and dysregulated expression levels of genes implicated in drug resistance mechanisms. The identification of biomarkers based on mutation profiles and expression levels is pivotal for elucidating the underlying mechanisms of altered drug responses and for refining combinatorial therapeutic strategies in the field of oncology. Utilizing comprehensive ...